|This Slide: #22 of 100|
Slide #22. Zimmer Holdings, Inc. — Biomet, Inc.
Zimmer Holdings, Inc. (ZMH)
Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ("Zimmer" or the "Company") and Biomet, Inc.'s parent company ("Biomet") today announced that their respective Boards of Directors have approved a definitive agreement under which Zimmer will acquire Biomet in a cash and stock transaction valued at approximately $13.35 billion, including the assumption of net debt. The transaction, which is subject to customary closing conditions and regulatory approvals, is expected to close in the first quarter of 2015.
Zimmer Holdings is engaged in the design, development, manufacture and marketing of orthopaedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products. Co.'s primary customers include orthopaedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, and healthcare dealers. Co. manages its operations through three geographic segments: the Americas, which is comprised of the U.S. and includes other North, Central and South American markets; Europe, which is comprised of Europe and includes the Middle East and African markets; and Asia Pacific, which is comprised of Japan and includes other Asian and Pacific markets.
Open the ZMH Page at The Online Investor »
Buy (3.42 out of 4)
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite